Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...
LVMH has reclaimed its spot as the biggest company in Europe, overtaking Novo Nordisk after a significant drop in the ...
Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...
Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.
The U.S. Department of Agriculture is urging poultry producers to intensify bird flu testing. The WHO is advocating for U.S.
President-elect Donald Trump says he “most likely” will give TikTok 90 more days to work out a deal that would allow the ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback